Skip to main content
BPRE
NYSE Unknown

Bluerock Private Real Estate Fund Finalizes $250M Convertible Preferred Share Offering with Significant Dilution Risk

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
8
Price
$16.26
Mkt Cap
0
52W Low
$13.75
52W High
$18.265
Market data snapshot near publication time

summarizeSummary

Bluerock Private Real Estate Fund finalized a $250 million offering of convertible preferred shares, securing substantial capital but explicitly warning of significant potential dilution for common shareholders upon conversion.


check_boxKey Events

  • Finalized $250 Million Preferred Share Offering

    The company is offering up to 25 million Series A and Series B Convertible and Perpetual Preferred Shares, with an aggregate liquidation preference of $250 million at $10.00 per share. Net proceeds to the company are estimated at $227.5 million.

  • Convertible Preferred Shares with 7.00% Dividend

    The preferred shares carry a fixed annual dividend rate of 7.00% ($0.70 per share per year), payable monthly. They are convertible into common shares at the holder's option semi-monthly, or at the issuer's option after two years.

  • Significant Dilution Risk for Common Shareholders

    The filing explicitly states there is no cap on the number of common shares that can be issued upon conversion, warning that a lower common share price at conversion would lead to greater dilution. This is particularly relevant as common shares currently trade at a significant discount to NAV.

  • Use of Proceeds for General Corporate Purposes

    Proceeds from the offering are intended to acquire investments, make distributions to shareholders, pay expenses, repay outstanding indebtedness, and for other general working capital purposes.


auto_awesomeAnalysis

Bluerock Private Real Estate Fund has finalized the terms for an offering of up to 25 million Series A and Series B Convertible and Perpetual Preferred Shares, with an aggregate liquidation preference of $250 million. This prospectus supplement (424B5) follows the N-2ASR registration filed on April 30, 2026, providing the specific pricing and terms of the offering. The net proceeds to the company are estimated at $227.5 million, which will be used for investments, distributions, debt repayment, and general working capital. While the capital raise provides significant financial flexibility, the filing explicitly warns of substantial dilution risk for existing common shareholders, as there is no cap on the number of common shares that can be issued upon conversion, especially if conversions occur when common shares trade at a discount to Net Asset Value (NAV). The common shares currently trade at a notable discount to their NAV ($16.26 market price vs. $23.52 NAV as of May 1, 2026).

At the time of this filing, BPRE was trading at $16.26 on NYSE in the Unknown sector. The 52-week trading range was $13.75 to $18.27. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed BPRE - Latest Insights

BPRE
May 07, 2026, 8:35 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
BPRE
May 04, 2026, 5:20 PM EDT
Filing Type: 424B5
Importance Score:
8
BPRE
Apr 30, 2026, 5:28 PM EDT
Filing Type: N-2ASR
Importance Score:
8